Literature DB >> 9182944

Protection against oxidative stress-induced neuronal cell death--a novel role for RU486.

C Behl1, T Trapp, T Skutella, F Holsboer.   

Abstract

Free radicals and oxidative stress-induced neuronal cell death have been implicated in a variety of neurological disorders. Therefore, neuroprotection is of primary interest in basic and preclinical neuroscience. Here it is shown that RU486 (mifepristone), a potent antagonist of progesterone and glucocorticoid receptors, protects rat primary hippocampal neurons, clonal mouse hippocampal cells and organotypic hippocampal slice cultures against oxidative stress-induced neuronal cell death. 10(-5) M RU486 prevents intracellular peroxide accumulation and cell death induced by amyloid beta protein, hydrogen peroxide and glutamate, neurotoxins that have been implicated in certain neurodegenerative disorders, including Alzheimer's disease. RU486 has a significant protective effect that is independent of the presence and activation of glucocorticoid or progesterone receptors. The neuroprotective activity of this well-studied drug may have an impact on therapeutic interventions for neurodegenerative conditions which involve peroxidation processes, such as stroke and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182944     DOI: 10.1111/j.1460-9568.1997.tb01442.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  24 in total

1.  Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity.

Authors:  E Gursoy; A Cardounel; M Kalimi
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex.

Authors:  M Singh
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 3.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 4.  Oxidative Stress and the Central Nervous System.

Authors:  Samina Salim
Journal:  J Pharmacol Exp Ther       Date:  2016-10-17       Impact factor: 4.030

5.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

Review 6.  New aspects of progesterone interactions with the actin cytoskeleton and neurosteroidogenesis in the cerebellum and the neuronal growth cone.

Authors:  Lisa Wessel; Laura Olbrich; Beate Brand-Saberi; Carsten Theiss
Journal:  J Histochem Cytochem       Date:  2014-08-20       Impact factor: 2.479

7.  The steroid RU486 induces UCP1 expression in brown adipocytes.

Authors:  Ana M Rodríguez; Andreu Palou
Journal:  Pflugers Arch       Date:  2004-08-27       Impact factor: 3.657

Review 8.  Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury.

Authors:  Qian Li; Xiaoning Han; Jian Wang
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

9.  Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum.

Authors:  A M Ghoumari; I Dusart; M El-Etr; F Tronche; C Sotelo; M Schumacher; E-E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

10.  Selective transcriptional regulation of aromatase gene by vitamin D, dexamethasone, and mifepristone in human glioma cells.

Authors:  Josue G Yague; Luis M Garcia-Segura; Iñigo Azcoitia
Journal:  Endocrine       Date:  2008-12-31       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.